Keith J. Miller

University of Queensland — Australia

Engineering · Physical Sciences

29h-index4.3kcitations147works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Fatigue and fracture mechanics(28), Natural Language Processing Techniques(18), Neurotransmitter Receptor Influence on Behavior(11), Receptor Mechanisms and Signaling(11), Topic Modeling(10)

Publications147 total

FinChain: Adaptation of Blockchain Technology in Finance and Business - An Ethical Analysis of Applications, Challenges, Issues and Solutions
International Journal of Emerging and Disruptive Innovation in Education VISIONARIUM·2023· 12 citedOpen Access
Gene, Oligonucleotide, and Ribozyme Therapy in the Eye
2021
ETHICS-2021 Special Session 5: Author meets the critics - ‘Engineering Ethics, Contemporary and Enduring Debates' by Deborah Johnson: ETHICS-2021 Author-Meets-Critics Session, Sunday October 31,2021,9:15-10:45 AM EDT
2021Open Access
Moral Responsibility for Computing Artifacts: Five Rules, Version 27
2020· 1 citedOpen Access
The Boeing 737 MAX: Lessons for Engineering Ethics
Science and Engineering Ethics·2020· 118 citedOpen Access
Applying a Social-Relational Model to Explore the Curious Case of hitchBOT
Philosophical studies series·2019· 3 cited
Mars Soiling Sensor™
2018· 23 cited
Mars™ Soiling Sensor
EU PVSEC·2018· 7 citedOpen Access
Utilization of an Active Site Mutant Receptor for the Identification of Potent and Selective Atypical 5-HT<sub>2C</sub>Receptor Agonists
Journal of Medicinal Chemistry·2017· 16 citedOpen Access
Gender and Race in the Timing of Requests for Ethics Consultations: A Single-Center Study
The Journal of Clinical Ethics·2016· 9 cited
Case Complexity and Quality Attestation for Clinical Ethics Consultants
The Journal of Clinical Ethics·2015· 3 cited
Handling entities in MT/CAT/HLT
Conference of the Association for Machine Translation in the Americas·2014
Discovery of 5-Chloro-4-((1-(5-chloropyrimidin-2-yl)piperidin-4-yl)oxy)-1-(2-fluoro-4-(methylsulfonyl)phenyl)pyridin-2(1<i>H</i>)-one (BMS-903452), an Antidiabetic Clinical Candidate Targeting GPR119
Journal of Medicinal Chemistry·2014· 45 citedOpen Access
Synthesis and structure–activity relationship of dihydrobenzofuran derivatives as novel human GPR119 agonists
Bioorganic & Medicinal Chemistry Letters·2014· 21 citedOpen Access
Synthesis and SAR of potent and selective tetrahydropyrazinoisoquinolinone 5-HT2C receptor agonists
Bioorganic & Medicinal Chemistry Letters·2013· 15 citedOpen Access
How to Handle Field Station Data: Two Views
2013
Synthesis and SAR of 2,3,3a,4-tetrahydro-1H-pyrrolo[3,4-c]isoquinolin-5(9bH)-ones as 5-HT2C receptor agonists
Bioorganic & Medicinal Chemistry Letters·2012· 15 citedOpen Access
Quality: The perspective that counts most.
PubMed·2012
International Multicultural Name Matching Competition: Design, Execution, Results, and Lessons Learned
2012
Solder Void Formation in Lead Free Solder
ECS Meeting Abstracts·2012· 1 citedOpen Access
page 1 of 8Next →

Frequent Co-authors

Lawrence W. Fitzgerald(6), Milt Teitler(5), Dean A. Wacker(5), Sarah E. Malmstrom(5), Jeffrey A. Robl(5), Paul J. Gilligan(4), Karen A. Rossi(4), Ginger Wu(4), Ge Zhang(3), Harvey Wong(3), Scott Grossman(3), David W. Robertson(3), R. Akid(3), Chen-Pin Hung(3), Mary Jane Cullen(3), Mary Ann Pelleymounter(3), Anil K. Ratty(3), Florence Reeder(3), Richard A. Glennon(2), Todd Clarke(2)